Smiths Industries Appoints New Executive Director
Lawrence Kinet to Take The Helm
LONDON-Lawrence Kinet has been appointed executive director of Smiths Industries plc and will replace George M. Kennedy CBE as head of Smiths Industries Medical Systems when Kennedy retires on August 4, 2000. Kinet earned his BSc at the University of Birmingham, UK, in 1968 and his MBA from the University of Chicago in 1970. From 1973-1988, Kinet held various positions at Baxter International Inc. concluding his career there as Corporate VP & President, World Trade Group. Subsequently he joined The Kensington Group as Managing Partner from 1989-1991 and from 1991-1994 he was the Chairman & CEO of Oculon Corporation. Most recently, Kinet held the position of Chairman, President & CEO of Aksys Ltd from 1994-1999. A US citizen, Kinet will relocate to Smiths Industries headquarters in London.
Advancing Infection Prevention With Diagnostic Innovation: Insights From Alesia McKeown, PhD
September 17th 2024Alesia McKeown, PhD, discusses the pivotal role of cutting-edge diagnostic technologies in enhancing infection prevention, especially in high-risk health care environments, during an interview with Infection Control Today.
The Role of Accurate Testing in Preventing Respiratory Illnesses: Insights from Dr. Aparna Ahuja
September 17th 2024On Get Ready for Flu Day, Dr. Aparna Ahuja discusses the importance of accurate respiratory illness testing, the risks of self-diagnosis, and the role of infection prevention personnel in public health education.
How Cleaning Medical Equipment Directly Affects Patient Safety and Equipment Longevity
September 16th 2024Hospital-associated infections affect over 1 million US patients annually. Proper medical equipment cleaning and sterilization significantly reduce infection risks, improving patient outcomes and safety.
Top 3 Secrets to Effective Infection Prevention and Control Through Strategic MDRO Surveillance
September 13th 2024Sean Brown’s 2024 Disease Prevention Summit presentation emphasized leveraging technology, prioritizing high-risk patients, and environmental surveillance to enhance infection prevention and control strategies.
